Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 17/20 | 0.57 |
| ▸ | RET | P07949 | 2/20 | 0.37 |
| ▸ | GFRA3 | O60609 | 2/20 | 0.37 |
| ▸ | GFRA2 | O00451 | 1/20 | 0.35 |
| ▸ | GFRA1 | P56159 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25474727 | 0.91 | FFAR1 (0.69) | FFAR1 | |
| SCHEMBL25474370 | 0.88 | FFAR1 (0.64) | FFAR1 | |
| SCHEMBL25474728 | 0.85 | FFAR1 (0.77) | FFAR1 | |
| SCHEMBL25475835 | 0.85 | FFAR1 (0.69) | FFAR1 | |
| SCHEMBL25475836 | 0.79 | FFAR1 (0.77) | FFAR1 | |
| SCHEMBL18101343 | 0.75 | FFAR1 (0.83) | FFAR1 | |
| SCHEMBL25474512 | 0.73 | FFAR1 (0.41) | FFAR1 | |
| SCHEMBL18101337 | 0.73 | FFAR1 (0.89) | FFAR1 | |
| SCHEMBL25474322 | 0.73 | FFAR1 (0.46) | FFAR1 | |
| SCHEMBL25474329 | 0.73 | FFAR1 (0.46) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151037-A1 | GPR40 AGONISTS | KALLYOPE, INC. | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151037-A1 | GPR40 AGONISTS | GPR119, GPR65, GLP1R | FFAR1 10/4885RET 1106/4885GFRA3 722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.